Processa Pharmaceuticals, Inc.
PCSANasdaqCIK 1533743HealthcareFiscal year ends Dec 31
Reports and events: 256 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-2216:37 ET | DEF 14A | Proxy statementPeriod 2026-11-30 | 0001140361-26-040520 |
| 2026-10-0507:21 ET | 8-K/A | 8.01 Other events; 9.01 Financial statements and exhibits | 0001140361-26-038535 |
| 2026-08-1416:06 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001493152-26-038334 |
| 2026-08-0417:25 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-26-036032 |
| 2026-07-2907:35 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-26-035099 |
| 2026-06-1816:05 ET | DEF 14A | Proxy statementPeriod 2026-06-18 | 0001493152-26-029326 |
| 2026-05-0716:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001493152-26-021721 |
| 2026-04-3017:14 ET | 10-K/A | Annual report, amendedPeriod 2025-12-31 | 0001493152-26-020731 |
| 2026-04-3017:11 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-26-020728 |
| 2026-03-1816:05 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001493152-26-011204 |
| 2026-02-2311:00 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002081456-26-000002 |
| 2026-02-1916:05 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001493152-26-007469 |
| 2026-01-0708:30 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-26-000733 |
| 2025-12-1511:00 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-25-027680 |
| 2025-11-0616:07 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001493152-25-021069 |
| 2025-10-1512:28 ET | SCHEDULE 13D/A | Ownership report, active investor, amended | 0002081456-25-000003 |
| 2025-09-1610:19 ET | 8-K/A | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013648 |
| 2025-09-1219:45 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-013108 |
| 2025-09-1010:42 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-012966 |
| 2025-09-0217:13 ET | 8-K | 5.07 Shareholder vote results | 0001493152-25-012567 |
| 2025-08-2517:21 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001641172-25-025421 |
| 2025-08-1408:30 ET | 8-K/A | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-023736 |
| 2025-08-1314:50 ET | SCHEDULE 13D | Ownership report, active investor | 0002081456-25-000001 |
| 2025-08-1308:30 ET | DEF 14A | Proxy statementPeriod 2025-08-13 | 0001493152-25-011883 |
| 2025-08-0817:17 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001493152-25-011775 |
| 2025-08-0708:52 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001493152-25-011685 |
| 2025-08-0708:30 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-011680 |
| 2025-07-2516:05 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-25-011419 |
| 2025-07-1816:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-25-011305 |
| 2025-07-1512:32 ET | 8-K | 5.07 Shareholder vote results | 0001641172-25-019663 |
| 2025-07-0109:00 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-017288 |
| 2025-06-3017:08 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001641172-25-017185 |
| 2025-06-1817:29 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015654 |
| 2025-06-1710:32 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001641172-25-015355 |
| 2025-06-1308:01 ET | S-1 | Registration statement | 0001641172-25-014967 |
| 2025-05-1216:05 ET | DEF 14A | Proxy statementPeriod 2025-05-12 | 0001641172-25-009671 |
| 2025-05-0816:06 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001641172-25-009252 |
| 2025-03-2016:31 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001641172-25-000070 |
| 2025-02-1110:32 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-005830 |
| 2025-02-1016:05 ET | 8-K | 3.01 Delisting notice | 0001493152-25-005633 |
| 2025-01-3017:20 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-25-004298 |
| 2025-01-2708:34 ET | S-1/A | Registration statement, amended | 0001493152-25-003720 |
| 2025-01-1606:24 ET | S-1/A | Registration statement, amended | 0001493152-25-002455 |
| 2024-12-2016:31 ET | S-1 | Registration statement | 0001493152-24-051075 |
| 2024-11-0616:00 ET | 8-K | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001493152-24-043821 |
| 2024-10-3016:05 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001493152-24-043058 |
| 2024-10-0216:36 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-039220 |
| 2024-08-2808:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-034115 |
| 2024-08-1316:15 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001493152-24-031622 |
| 2024-07-3008:00 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-24-029514 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:47 ET. Listed shows no prices and gives no investment advice.